Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from IDEXX

Are Wall Street Analysts Bullish on IDEXX Laboratories Stock?

IDEXX Laboratories has outperformed the broader market over the past year, and analysts remain moderately bullish about the stock’s prospects.

How Is IDEXX Laboratories’ Stock Performance Compared to Other Health Care Stocks?

How Is IDEXX Laboratories’ Stock Performance Compared to Other Health Care Stocks?

Although IDEXX Laboratories has outperformed the healthcare sector over the past year, analysts remain cautiously optimistic about the stock’s prospects.

What to Expect From IDEXX Laboratories’ Q3 2025 Earnings Report

What to Expect From IDEXX Laboratories’ Q3 2025 Earnings Report

IDEXX Laboratories is set to announce its third-quarter results next month, with analysts forecasting robust double-digit growth in earnings.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Idexx Laboratories Stock: Is Wall Street Bullish or Bearish?

IDEXX Laboratories' stock has significantly outperformed the broader market over the past year, but analysts are cautiously bullish about its growth potential.

Why a Company You’ve Never Heard of Is One of the Best Nasdaq-100 Stocks of the Year

Going under the radar, shares of this vet tech company have been winners this year.

IDEXX Surpasses Earnings Expectations, Justifying Premium Valuation

Pet healthcare is witnessing a surge in demand as more households prioritize their pets’ well-being, driving companies in this sector to outperform expectations. This trend is reflected in IDEXX Laboratories Inc.‘s (NASDAQ:IDXX) recent financial results, showcasing significant growth and revised earnings guidance.

Here's What to Expect From IDEXX Laboratories' Next Earnings Report

IDEXX Laboratories is expected to release its fiscal second-quarter earnings next month, and analysts project a double-digit earnings growth.

inkl

Read news from The Economist, FT, and more,
with one subscription

Is IDEXX Laboratories Stock Outperforming the Dow?

Is IDEXX Laboratories Stock Outperforming the Dow?

IDEXX Laboratories has outpaced the Dow Jones Industrial Average this year, and analysts are reasonably upbeat about its future growth potential.

Is IDEXX Laboratories Stock Underperforming the Nasdaq?

Is IDEXX Laboratories Stock Underperforming the Nasdaq?

Despite IDEXX Laboratories’ underperformance relative to the broader Nasdaq Composite over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Do Wall Street Analysts Like IDEXX Laboratories Stock?

Do Wall Street Analysts Like IDEXX Laboratories Stock?

IDEXX Laboratories has significantly outperformed the broader market in 2025 and analysts remain bullish on the stock’s prospects.

Is IDEXX Laboratories Stock Underperforming the S&P 500?

Is IDEXX Laboratories Stock Underperforming the S&P 500?

IDEXX Laboratories has continued to underperform the S&P 500 over the past year, yet analysts remain moderately bullish on the stock’s prospects.

A Glimpse Into The Expert Outlook On IDEXX Laboratories Through 5 Analysts

A Glimpse Into The Expert Outlook On IDEXX Laboratories Through 5 Analysts

5 analysts have shared their evaluations of IDEXX Laboratories (NASDAQ:IDXX) during the recent three months, expressing a mix of bullish and bearish perspectives.

How Is IDEXX Laboratories' Stock Performance Compared to Other Healthcare Stocks?

How Is IDEXX Laboratories' Stock Performance Compared to Other Healthcare Stocks?

IDEXX Laboratories underperformed the broader healthcare sector, but Wall Street analysts remain moderately optimistic about the stock’s prospects.

Man dubbed ‘Britain’s Warren Buffett’ blames falling vet visits—not Nvidia—for poor fund performance

Man dubbed ‘Britain’s Warren Buffett’ blames falling vet visits—not Nvidia—for poor fund performance

Smith's popular fund has again underperformed the benchmark, prompting him to defend his Nvidia stance once more.

Get all your
news in one place.

100’s of premium titles.
One news app.

T2 Biosystems (TTOO) vs. IDEXX Laboratories (IDXX): Which Medical Stock Is Poised for More October Gains?

With an aging population worldwide, the rising prevalence of chronic diseases, and numerous technological advancements, the medical device sector stands primed for considerable growth and expansion. The industry tailwinds should benefit medical device stocks T2 Biosystems (TTOO) and IDEXX Laboratories (IDXX). However, which stock is poised for better gains this…

Zoetis vs. IDEXX Laboratories: Which Animal-Health Services Stock is a Better Buy?

Rising pet ownership and an increasing focus on healthy livestock have boosted the demand for animal healthcare solutions. Therefore, animal healthcare service providers Zoetis (ZTS) and IDEXX Laboratories (IDXX) should benefit. But the stocks of which of these two companies is a better buy now? Read on to learn our…

3 Pet Stocks to Buy and Hold in 2022

Despite rising pet care costs amid the Russia-Ukraine war and record-high inflation, the demand for pet care products remains strong. And because a significant increase in pet ownership amid the COVID-19 pandemic is expected to keep the demand high, we think it could be wise to scoop up shares of…

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

IDEXX Laboratories

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

345,309 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play